News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
17,782 Results
Type
Article (933)
Company Profile (3)
Press Release (16846)
Section
Business (3645)
Career Advice (5)
Deals (536)
Drug Development (5333)
Employer Resources (1)
FDA (505)
Job Trends (706)
News (9523)
Policy (727)
Tag
Academia (44)
Accelerated approval (3)
Adcomms (2)
Allergies (3)
Alliances (1082)
ALS (3)
Alzheimer's disease (63)
Antibody-drug conjugate (ADC) (47)
Approvals (559)
Artificial intelligence (10)
Autoimmune disease (3)
Best Places to Work (744)
Biosimilars (13)
Biotechnology (3)
Bladder cancer (32)
Brain cancer (12)
Breast cancer (132)
Cancer (894)
Cardiovascular disease (3)
Career advice (5)
CAR-T (16)
Cell therapy (47)
Cervical cancer (10)
Clinical research (5104)
Collaboration (53)
Compensation (2)
Complete response letters (1)
COVID-19 (65)
C-suite (18)
Data (599)
Depression (1)
Diabetes (5)
Diagnostics (51)
Digital health (3)
Drug discovery (3)
Earnings (1806)
Employer resources (1)
Events (3098)
Executive appointments (19)
FDA (672)
Frontotemporal dementia (1)
Funding (30)
Gene editing (1)
Gene therapy (2)
GLP-1 (13)
Government (91)
Grass and pollen (1)
Guidances (15)
Healthcare (382)
HIV (1)
Immunology and inflammation (7)
Immuno-oncology (9)
Indications (20)
Infectious disease (73)
Inflammatory bowel disease (5)
Influenza (6)
Intellectual property (9)
Interviews (1)
IPO (344)
Job creations (18)
Job search strategy (3)
Kidney cancer (1)
Layoffs (4)
Legal (44)
Liver cancer (25)
Lung cancer (171)
Lymphoma (71)
Manufacturing (14)
MASH (3)
Medical device (197)
Medtech (199)
Mergers & acquisitions (209)
Metabolic disorders (9)
Neurodegenerative disease (8)
Neuropsychiatric disorders (2)
Neuroscience (77)
NextGen: Class of 2026 (128)
Non-profit (51)
Obesity (1)
Opinion (2)
Ovarian cancer (47)
Pain (1)
Pancreatic cancer (71)
Parkinson's disease (6)
Patents (11)
Patient recruitment (28)
Peanut (2)
People (908)
Phase 1 (1326)
Phase 2 (2152)
Phase 3 (2318)
Pipeline (309)
Policy (1)
Postmarket research (78)
Preclinical (375)
Prostate cancer (29)
Radiopharmaceuticals (9)
Rare diseases (17)
Real estate (39)
Recruiting (1)
Regulatory (852)
Research institute (52)
Resumes & cover letters (2)
RSV (4)
Series A (3)
Series B (1)
Sickle cell disease (2)
Startups (52)
Stomach cancer (3)
Supply chain (2)
Vaccines (28)
Weight loss (1)
Date
Last 7 days (22)
Last 30 days (83)
Last 365 days (1353)
2026 (116)
2025 (1360)
2024 (1477)
2023 (1592)
2022 (1751)
2021 (1747)
2020 (1568)
2019 (1317)
2018 (1056)
2017 (949)
2016 (863)
2015 (918)
2014 (611)
2013 (449)
2012 (336)
2011 (346)
2010 (240)
Location
Africa (9)
Arizona (1)
Asia (1538)
Australia (345)
California (437)
Canada (144)
China (130)
Colorado (32)
Connecticut (20)
Delaware (46)
Europe (3806)
Florida (57)
Illinois (36)
India (1)
Indiana (23)
Iowa (1)
Japan (46)
Kansas (2)
Kentucky (2)
Maine (1)
Maryland (45)
Massachusetts (240)
Michigan (1)
Minnesota (11)
Missouri (1)
Montana (9)
Nevada (7)
New Jersey (224)
New York (188)
North Carolina (24)
Northern California (188)
Ohio (3)
Oklahoma (1)
Pennsylvania (67)
South America (11)
Southern California (201)
Tennessee (1)
Texas (67)
United States (1537)
Utah (18)
Virginia (2)
Washington D.C. (1)
Washington State (16)
Wisconsin (1)
17,782 Results for "ose immunotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for Lusvertikimab
January 29, 2026
·
8 min read
Press Releases
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
January 22, 2026
·
4 min read
Press Releases
OSE Immunotherapeutics Presents a Poster on OSE-Cytomask®, a Novel “Cis-Demasking” Cytokine Technology to Increase Therapeutic Index of Immunocytokines
November 10, 2025
·
5 min read
Press Releases
OSE Immunotherapeutics Announces Strategic Amendment to AbbVie’s Partnership on ABBV-230 Development
December 8, 2025
·
5 min read
Press Releases
OSE Immunotherapeutics Reports First Half 2025 Financial Results
October 16, 2025
·
8 min read
Press Releases
OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer
August 21, 2025
·
4 min read
Press Releases
OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
September 26, 2025
·
6 min read
Press Releases
OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation
September 5, 2025
·
7 min read
Press Releases
OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting
August 25, 2025
·
7 min read
Press Releases
OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General Meeting of September 30, 2025
September 9, 2025
·
3 min read
1 of 1,779
Next
